Schizophrenia Trial, Recruiting (NCT07213492)

Schizophrenia Trial, Recruiting NCT07213492 Sponsor: McMaster University Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT07213492 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are between 18 and 35 years old
People who have been diagnosed with bipolar disorder within the last 24 months
People who experienced psychosis and/or had limited awareness of their illness at the time of joining the study
People who can understand and speak English

Who may not be able to join:

People with a severe psychiatric condition that would make it unsafe for them to take part in the intervention
People with significant cognitive difficulties or a medical condition that would prevent them from participating in education or peer-support sessions
People with a current, active substance use disorder that may make it difficult to stay engaged with the intervention
People who do not speak English and would need language support to take part in study sessions
People who are already enrolled in another structured education or peer-support program that could affect the study's results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 905-522-1155

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07213492

Sponsor: McMaster University

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: 905-522-1155

More information: https://clinicaltrials.gov/study/NCT07213492

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are between 18 and 35 years old
People who have been diagnosed with bipolar disorder within the last 24 months
People who experienced psychosis and/or had limited awareness of their illness at the time of joining the study
People who can understand and speak English

Who may not be able to join:

People with a severe psychiatric condition that would make it unsafe for them to take part in the intervention
People with significant cognitive difficulties or a medical condition that would prevent them from participating in education or peer-support sessions
People with a current, active substance use disorder that may make it difficult to stay engaged with the intervention
People who do not speak English and would need language support to take part in study sessions
People who are already enrolled in another structured education or peer-support program that could affect the study's results

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

McMaster University

Registry

ClinicalTrials.gov

Start date

1 June 2026

Est. completion

1 May 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Feasibility of the Multi-Modal Transitional Care Intervention; Acceptability of the Multi-Modal Transitional Care Intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov